Covered recipient · General Payments record
KIMBERLY N CLOVIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$10,943.26
- Reported across 195 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,100.00 | 1 |
| Food and Beverage | $2,959.06 | 100 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $450.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MannKind Corporation | $5,929.24 | 10 |
| DEXCOM, INC. | $438.03 | 4 |
| Lilly USA, LLC | $299.55 | 18 |
| Medtronic, Inc. | $225.70 | 6 |
| Abbott Laboratories | $184.28 | 2 |
| Corcept Therapeutics | $178.90 | 7 |
| Novo Nordisk AS | $153.92 | 8 |
| Amgen Inc. | $148.05 | 7 |
| Radius Health, Inc. | $141.20 | 7 |
| SANOFI-AVENTIS U.S. LLC | $139.71 | 6 |
| Insulet Corporation | $139.51 | 4 |
| BETA BIONICS, INC. | $132.09 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $86.71 | 5 |
| Kyowa Kirin, Inc. | $46.69 | 2 |
| Xeris Pharmaceuticals, Inc. | $44.99 | 2 |
| CeQur Corporation | $44.86 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.93 | 2 |
| Antares Pharma, Inc. | $31.59 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $30.38 | 2 |
| Neurocrine BioSciences, Inc. | $20.56 | 1 |
| Esperion Therapeutics, Inc. | $17.42 | 1 |
| TOLMAR, INC. | $14.42 | 1 |
| Amneal Pharmaceuticals LLC | $14.25 | 1 |
| ABBVIE INC. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (102)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.